Antibiotic Resistance Market, By Disease Type (Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Others), By Pathogen Type (Acinetobacter Baumanni, Pseudomonas Aeruginosa, Staphylococcus Aureus, Streptococcus pneumoniae, Others), By Drug Class, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Antibiotic Resistance Market size was valued at USD 8,005.7 million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.
Antibiotic resistance is a grave concern as bacteria adapt to medications, rendering them less effective. This adaptation occurs within bacteria and affects their ability to infect both humans and animals. Infections caused by antibiotic-resistant bacteria are much harder to treat than those from non-resistant strains. Contributing factors to this problem include the overuse and misuse of antibiotics, coupled with inadequate infection prevention and control measures.
Addressing antibiotic resistance requires collective efforts across society, spanning nations, industries, and organizations. Investments in the development of new antibiotics and alternative therapies like bacteriophages and antimicrobial peptides are essential. A case in point is the rapid emergence and spread of Methicillin-Resistant Staphylococcus Aureus (MRSA), underscoring the urgency of responsible antibiotic usage, enhanced infection control protocols, and the quest for innovative antibiotics.
Antibiotic Resistance Market- Market Dynamics
- Increasing the prevalence of bacterial infection to increase market growth
The rise in antibiotic-resistant bacterial infections is fueling the demand for new and innovative treatments, potentially leading to market expansion. To combat antibiotic resistance, there is a growing urgency for the development of novel antibiotics, which may result in increased research and development investments from pharmaceutical companies. Recent global estimates reveal the significant burden of bacterial infections, with 7.7 million deaths attributed to them in 2019, representing 1 in 8 of all global deaths.
One promising avenue for accelerating antibiotic development is the integration of AI and machine learning in drug research. This offers a growth opportunity to expedite the creation of new antibiotics. However, it\'s important to note that antibiotic resistance is not widely recognized by the general population and even healthcare providers, potentially leading to incorrect prescribing and misuse.
- Antibiotic Resistance Market- Key Insights
- According to insights provided by our research analyst, the global Antibiotic Resistance market is anticipated to experience an annual growth rate of approximately 6.1% during the projected period from 2023 to 2030.
- In terms of disease types, Urinary Tract Infections were identified as having the largest market share in 2022.
- Meanwhile, among pathogen types, Acinetobacter Baumannii held the top position in 2022. In the drug class segment, Oxazolidinones emerged as the leading category in the same year.
- Furthermore, when considering end-user categories, Hospitals took the forefront in 2022.
- Finally, in the regional context, North America emerged as the primary revenue generator in 2022.
Antibiotic Resistance Market- Segmentation Analysis:
The global Antibiotic Resistance Market is structured around various factors, including Disease type, Pathogen Type, Drug class, End-User, and Region.
Among these categories, Disease type is divided into several segments, including Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, and others. Notably, Urinary Tract Infections hold a prominent position and drive market growth. UTIs are highly prevalent, especially among women, making them a common health concern. Traditionally, UTIs have been treated with antibiotics. However, the increasing challenge of antibiotic resistance is making the management and treatment of UTIs more complex.
Antibiotic Resistance Market- Geographical Insights
Geographically, the Antibiotic Resistance Market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region comprising individual countries contributing to the industry.
North America is set to take the lead in market growth, primarily due to the rising incidence of infectious diseases and increased healthcare spending. This region, particularly the United States, has faced several outbreaks of infectious diseases, some of which have exhibited antibiotic resistance. For instance, Methicillin-resistant Staphylococcus aureus (MRSA) has become a significant concern in numerous U.S. healthcare facilities and hospitals. Europe and the Asia Pacific are anticipated to drive demand for the Antibiotic Resistance Market, driven by the increasing need for effective antibiotic treatments.
Antibiotic Resistance Market- Competitive Landscape:
Antibiotic resistance stands out as a critical global issue, posing challenges in the fight against bacterial infections. As bacteria adapt and develop resistance to existing medications, the effectiveness of treatments diminishes, leading to prolonged illnesses, increased hospitalizations, and higher mortality rates. In response to this, pharmaceutical manufacturers have actively engaged in antibiotic research. However, due to economic pressures, some major pharmaceutical corporations like Pfizer, Merck, GlaxoSmithKline, and Roche have scaled down or abandoned their antibiotic research initiatives.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIBIOTIC RESISTANCE MARKET KEY PLAYERS
- Achaogen Inc
- Nabriva Therapeutics plc
- BioVersys AG
- Johnson & Johnson Services, Inc.
- Destiny Pharma plc
- Armata Pharmaceuticals, Inc.
- West Way Health
- The Medicines Company
- Merck & Co., Inc.
- Pfizer Inc.
- CARB-X
- Melinta Therapeutics LLC
- Novartis AG
- Vertex Pharmaceuticals Incorporated
- GSK plc.
- AbbVie Inc.
- Hoffmann-La Roche Ltd
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY DISEASE TYPE
- Urinary Tract Infection
- Intra-Abdominal Infections
- Blood Stream Infections
- Clostridium Difficile Infections
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY PATHOGEN TYPE
- Acinetobacter Baumannii
- Pseudomonas Aeruginosa
- Staphylococcus Aureus
- Streptococcus pneumoniae
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY DRUG CLASS
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY END-USER
- Hospitals
- Homecare
- Specialty Clinics
- Others
GLOBAL ANTIBIOTIC RESISTANCE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Antibiotic Resistance Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Antibiotic Resistance Market Snippet by Disease Type
2.1.2. Antibiotic Resistance Market Snippet by Pathogen Type
2.1.3. Antibiotic Resistance Market Snippet by Drug Class
2.1.4. Antibiotic Resistance Market Snippet by End-User
2.1.5. Antibiotic Resistance Market Snippet by Country
2.1.6. Antibiotic Resistance Market Snippet by Region
2.2. Competitive Insights
3. Antibiotic Resistance Key Market Trends
3.1. Antibiotic Resistance Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Antibiotic Resistance Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Antibiotic Resistance Market Opportunities
3.4. Antibiotic Resistance Market Future Trends
4. Antibiotic Resistance Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Antibiotic Resistance Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Antibiotic Resistance Market Landscape
6.1. Antibiotic Resistance Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Antibiotic Resistance Market – By Disease Type
7.1. Overview
7.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
7.1.2. Urinary Tract Infection
7.1.3. Intra-Abdominal Infections
7.1.4. Blood Stream Infections
7.1.5. Clostridium Difficile Infections
7.1.6. Others
8. Antibiotic Resistance Market – By Pathogen Type
8.1. Overview
8.1.1. Segment Share Analysis, By Pathogen Type, 2022 & 2030 (%)
8.1.2. Acinetobacter Baumannii
8.1.3. Pseudomonas Aeruginosa
8.1.4. Staphylococcus Aureus
8.1.5. Streptococcus pneumoniae
8.1.6. Others
9. Antibiotic Resistance Market – By Drug Class
9.1. Overview
9.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
9.1.2. Oxazolidinones
9.1.3. Lipoglycopeptides
9.1.4. Tetracyclines
9.1.5. Others
10. Antibiotic Resistance Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
10.1.2. Hospitals
10.1.3. Homecare
10.1.4. Specialty Clinics
10.1.5. Others
11. Antibiotic Resistance Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Antibiotic Resistance Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Antibiotic Resistance Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Antibiotic Resistance Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Antibiotic Resistance Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Antibiotic Resistance Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Pathogen Type, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Antibiotic Resistance Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Achaogen Inc
12.2.2. Nabriva Therapeutics plc
12.2.3. BioVersys AG
12.2.4. Johnson & Johnson Services, Inc.
12.2.5. Destiny Pharma plc
12.2.6. Armata Pharmaceuticals, Inc.
12.2.7. West Way Health
12.2.8. The Medicines Company
12.2.9. Merck & Co., Inc.
12.2.10. Pfizer Inc.
12.2.11. CARB-X
12.2.12. Melinta Therapeutics LLC
12.2.13. Novartis AG
12.2.14. Vertex Pharmaceuticals Incorporated
12.2.15. GSK plc.
12.2.16. AbbVie Inc.
12.2.17. F. Hoffmann-La Roche Ltd
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
